Skip to content
Home/Companies/Biotech/LoQus23 Therapeutics
LoQus23 Therapeutics

LoQus23 Therapeutics

Biotech·UK·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns LoQus23 Therapeutics?

LoQus23 Therapeutics is currently owned by SV Health Managers through Dementia Discovery Fund (2015 vintage), since 2019.

Hand-verified · updated 2026-06-30

SV Health Managers
Investor
SV Health Managers
Dementia Discovery Fund · 2015 · Impact

Key facts

HQUK
SectorBiotech
StatusActive
Websiteloqus23.com

More from Dementia Discovery Fund

Other portfolio companies in the same fund.

Montara Therapeutics
Active
BiotechUS· 2024
TRIMTECH Therapeutics
TRIMTECH Therapeutics
Active
BiotechUK· 2023
Amphista Therapeutics
Amphista Therapeutics
Active
BiotechUK· 2022
AviadoBio
AviadoBio
Active
BiotechUK· 2021
Harness Therapeutics
Harness Therapeutics
Active
BiotechUK· 2020
NRG Therapeutics
Active
BiotechUK· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track LoQus23 Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy LoQus23 Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on LoQus23 Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue